Organovo Holdings Inc (NASDAQ:ONVO) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: October 8, 2016
Zacks Investment Research has downgraded Organovo Holdings Inc (NASDAQ:ONVO) to Hold in a statement released on 10/06/2016.
Boasting a price of $3.97, Organovo Holdings Inc (NASDAQ:ONVO) traded -5.12% lower on the day. With the last stock price close up 9.58% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Organovo Holdings Inc has recorded a 50-day average of $3.92 and a two hundred day average of $3.39. Volume of trade was up over the average, with 1,101,791 shares of ONVO changing hands over the typical 986,600
With a total market value of $0, Organovo Holdings Inc has with a one year low of $1.60 and a one year high of $4.99 .
Brief Synopsis About Organovo Holdings Inc (NASDAQ:ONVO)
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.